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A modified new method for estimating smoking-attributable 




Preston, Glei, and Wilmoth (2010) recently proposed an innovative regression-based 
method for estimating smoking-attributable mortality in developed countries based on 
observed lung cancer death rates. Their estimates for females, however, differ 
appreciably from some published estimates. This article presents a modified version of 
the Preston, Glei, and Wilmoth method that includes an age-period interaction term in 
its model. This modified version produces improved estimates of smoking-attributable 
mortality that are consistent with results from a modified version of the Peto-Lopez 
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1. Introduction and review of existing methods for estimating  
    smoking-attributable mortality 
Attention has recently been directed to methods that estimate smoking-attributable 
mortality because of their usefulness in examining the role of smoking in mortality 
differences among developed countries. Several studies have shown a divergence in 
mortality trends at older ages among developed countries in recent decades, particularly 
for females. Meslé and Vallin (2006) observed that life expectancy at age 65 for 
females increased only slightly from 1984 to 2000 in the U.S. and the Netherlands, even 
as female e65 increased steadily in France and Japan during this period. Janssen, Kunst, 
and Mackenbach (2007) found similar differences in mortality declines at ages 80 and 
over in seven European countries, with declines steadily continuing in France, but 
stagnating in countries such as Denmark and the Netherlands. They concluded that 
these differences among countries were largely due to differences in smoking-related 
mortality. The effect of previous cigarette smoking on these mortality trends deserves 
particular attention. Decades of medical and epidemiological research have 
demonstrated that cigarette smoking is the leading cause of preventable mortality in the 
U.S. and most other developed countries (DHHS 2000; Ezzati et al. 2002). More 
specifically, Staetsky (2009) recently showed that smoking is a principal cause of 
observed mortality differences among selected developed countries. Staetsky also used 
the indirect Peto-Lopez method to estimate mortality in these countries in the absence 
of smoking-attributable deaths.   
Various methods have been proposed and used to measure smoking-attributable 
mortality in populations. Pérez-Ríos and Montes (2008) provided a useful systematic 
review of these methods. They found that two general types of methods were most 
commonly used in the research literature. Both types of methods generally calculate the 
fraction of deaths in a population that are attributable to smoking (smoking-attributable 
fraction or SAF). The first group of methods, which Pérez-Ríos and Montes called 
“prevalence-based analysis,” calculate SAF from data for current and former smoker 
prevalence, usually obtained from surveys, and relative risks for smoking, usually 
obtained from prospective cohort studies, such as the American Cancer Society’s 
Cancer Prevention Study II (CPS II). Pérez-Ríos and Montes cited the method used by 
the U.S. Centers for Disease Control and Prevention (CDC) to estimate smoking-
attributable mortality as an example of a prevalence-based analysis. The CDC method 
(2008) estimates adult smoking-attributable mortality using current and former smoker 
prevalence data from the National Health Interview Survey (NHIS), with relative risks 
for 19 causes obtained from the CPS-II. It estimates infant smoking-attributable 
mortality using maternal smoking prevalence from birth certificate data and relative 
risks for four causes for infants of mothers who smoke obtained from a meta-analysis of Demographic Research: Volume 23, Article 14 
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epidemiologic studies. Separate methods are used by the CDC to estimate smoking-
attributable mortality due to secondhand smoke and burns. 
Pérez-Ríos and Montes identified the indirect method presented by Peto et al. 
(1992, 1994) as the other commonly used method for estimating smoking-attributable 
mortality. The method, commonly called the Peto-Lopez method, estimates smoking-
attributable mortality by sex and age group in a national population in two general 
steps. First, observed lung cancer death rates in the national population are compared to 
lung cancer death rates among non-smokers in a study population. The Peto-Lopez 
method uses CPS-II participants for its study population. (Smoking status was 
identified at baseline in the CPS-II and non-smokers reported that they had never 
smoked regularly.) All excess lung cancer mortality in the national population is 
attributed to smoking. Second, estimated smoking exposure and relative risks of 
smoking are used to calculate the smoking-attributable fractions of mortality from other 
causes. Smoking exposure in the national population is estimated by calculating the 
proportion of smokers and non-smokers that would have produced observed lung 
cancer death rates, based on the assumption that these smokers and non-smokers had 
the same lung cancer mortality as current and non-smokers in the CPS-II. Relative risks 
of mortality for selected causes are calculated from mortality for current and non-
smokers in the CPS-II. Only half of the excess relative risk for causes other than lung 
cancer is attributed to smoking to control for potential confounding factors. The 
smoking-attributable fractions of deaths by cause estimated for persons aged 75-79 are 
also used for those 80 and over because of concerns about data quality at older ages. No 
deaths from cirrhosis or external causes, such as accidents, are attributed to smoking. 
Pérez-Ríos and Montes also identified two less common classes of methods to 
estimate smoking-attributable mortality in the literature. One class was “excess 
mortality methods,” which generally compare the mortality between smokers and non-
smokers in a population and calculate the difference. Pérez-Ríos and Montes cited as an 
example of this class a recent study conducted by Rogers et al. (2005). These 
researchers calculated relative mortality risks for seven smoker groups (heavy, 
moderate, and light current smoker; heavy, moderate, and light former smoker; and 
never smoker) by sex from 1990 NHIS supplement data linked to mortality follow-up, 
controlling for a variety of demographic characteristics and mortality risk factors. They 
then applied these risks to the numbers of people in each smoker group in the U.S. in 
2000, based on NHIS smoking prevalence data, to estimate the numbers of deaths 
attributable to smoking. The final class of methods identified by Pérez-Ríos and 
Montes, “predictive models,” was represented by one research effort, the Prevent 
simulation model developed in the Netherlands. 
Preston, Glei, and Wilmoth (2010) recently proposed an innovative regression-
based method to estimate smoking-attributable mortality that is useful in examining the Rostron: A modified new method for estimating smoking-attributable mortality in high-income countries 
role of smoking in mortality differences among developed countries. Their method is 
generally distinct from the existing classes of methods outlined by Pérez-Ríos and 
Montes. It is most similar to the excess mortality method presented by Rogers et al., in 
that both methods use a regression approach to estimate the effect of smoking on 
overall mortality. The particular approaches of the two methods are substantially 
different, however. The Rogers et al. method estimates relative mortality risks for 
persons by smoking status, controlling for various demographic factors and possible 
confounding risk factors. The Preston, Glei, and Wilmoth method, in contrast, estimates 
the relative effect of excess lung cancer mortality due to smoking on overall mortality 
by age for national populations. Preston, Glei, and Wilmoth found that results from 
their method were consistent with results produced by the Peto-Lopez method, and 
concluded that this consistency tended to validate both methods. 
This study examines the Preston, Glei, and Wilmoth (henceforth PGW) method 
and its estimates of smoking-attributable mortality. It finds that the age distribution of 
smoking-attributable deaths produced by the method differs appreciably from the age 
distribution of deaths produced by other methods. This study proposes the inclusion of 
an age-period interaction term in the regression model of the PGW method, and shows 
that this revised model (henceforth PGW-R) produces results that are more consistent 
with published estimates. The study also shows that results from the PGW-R method 
are consistent with results from a modified version of the Peto-Lopez method.    
 
 
2. The PGW method and an evaluation 
Preston, Glei, and Wilmoth (2010) presented a regression-based method for estimating 
smoking-attributable mortality that uses lung cancer death rates as a proxy for the effect 
of smoking on mortality generally. They used a negative binomial regression approach 
and modeled death rates at ages 50-54, 55-59, …, 80-84, and 85+ for causes other than 
lung cancer as a function of lung cancer death rates and other variables. They modeled 
mortality for males and females separately. Specifically, their regression equation was: 
 
) ( ) ( ) ( ln a L La L Lt L L c ct c c t t a a O X M t M M X t X X X M × + × + + × + + + = β β β β β β β
,   [1] 
 
where MO represents the death rate from causes other than lung cancer by age, sex, 
year, and country; Xa is a set of dummy variables for each age group, Xt is a set of 
dummy variables for each year, Xc is a set of dummy variables for each country, (t x Xc) 
is an interaction term between year as a linear variable and country, ML represents the 
lung cancer death rate, (ML x t) is an interaction term between the lung cancer death rate 
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and year as a linear variable, and (ML x Xa) is an interaction term between the lung 
cancer death rate and age group. Preston, Glei, and Wilmoth used 80+ as the highest 
age group for this last interaction term. 
Preston, Glei, and Wilmoth fit this model using mortality data by cause from the 
World Health Organization (WHO) Mortality Database (2010), and all-cause mortality 
data and exposure data from the Human Mortality Database (2010). They included 20 
high-income countries that are members of the Organisation for Economic Co-operation 
and Development (OECD) in their analysis. They calculated the fraction of lung cancer 
deaths attributable to smoking (AL) by country-year-sex-age group by comparing 
observed lung cancer death rates to expected lung cancer death rates for non-smokers. 
They obtained lung cancer death rates for non-smokers from the American Cancer 














L λ  is the expected lung cancer death rate among non-smokers. They then found 
the smoking-attributable fraction of deaths from causes other than lung cancer (AO) 
from the coefficient of the effect of lung cancer mortality on mortality generally,
/
L β , 
obtained from the regression model for MO. This coefficient is equal to the sum of the 
coefficients L β , Lt β , and  La β   from Equation 1. AO  can be found with the following 
formula: 
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where  L D ,  O D , and  D are the observed numbers of deaths from lung cancer, all causes 
other than lung cancer, and all causes, respectively. 
Results from the PGW method differ from some other published estimates, 
particularly for females. For the U.S. in 2003, Preston, Glei, and Wilmoth found that 
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244,000 deaths for males and 271,000 deaths for females aged 50 and over were due to 
smoking. The Centers for Disease Control and Prevention (CDC) estimated that, during 
the period from 2000 to 2004, an average of 270,000 deaths for males and 174,000 
deaths for females in the U.S. each year were attributable to smoking (2008). Rogers et 
al. (2005) found that approximately 161,000 deaths for males aged 50 and over, and 
115,000 deaths for females aged 50 and over were due to smoking. These estimates are 
probably somewhat lower than actual values. The estimates from Rogers et al. do not 
include deaths attributable to passive smoking exposure, and the CDC estimates that 
approximately 10% of all deaths due to smoking in the U.S. are attributable to this 
exposure (2008). Rogers et al. also used smoking status as reported at the beginning of 
a seven-year follow-up period to determine relative mortality risks for various classes of 
smokers. Taylor et al. (2002) showed that adjustment for change in smoking status 
during a 14-year follow-up period in the CPS-II study increased estimates of relative 
mortality risk for smokers by 8% to 28%, compared to continuing use of smoking status 
as reported at baseline. 
Estimates of smoking-attributable mortality by age group from the PGW method 
also differ from some estimates obtained from other methods. Preston, Glei, and 
Wilmoth did not report smoking-attributable deaths by age, but their published 
estimates of
/
L β   by age group and supplementary data can be used to produce these 
estimates. The PGW method estimates that approximately 244,000 deaths among U.S. 
females in 2000 were due to smoking. Of these deaths, approximately 57% were among 
women aged 80 and over. This large proportion results for the most part from the PGW 
method’s much larger estimate of
/
L β  for the 80+ age group than for other older age 
groups for females. For example,
/
L β  in 2003 was four times larger for the female 80+ 
age group than for the female 75-79 age group. The comparable increase in
/
L β  for males 
from the 75-79 age group to the 80+ age group was only 0.042 to 0.050. As suggested 
by Equation 3, 
/
L β  by sex should generally decrease with age, due to increases with age 
in lung cancer mortality attributable to smoking, and/or to decreases in the proportion of 
mortality from other causes attributable to smoking. Preston, Glei, and Wilmoth 
suggested that the increase in
/
L β  for the open-ended age group might be due to under-
classification of lung cancer deaths at these advanced ages. This explanation might 
account for the slight increase in
/
L β   observed for males, but seems insufficient to 
account for the quadrupling in
/
L β  for females from ages 75-79 to 80+.   
The age distribution of smoking-attributable deaths for females estimated by the 
PGW method also differs somewhat from the distribution produced by the Peto-Lopez 
method, which is the method that Preston, Glei, and Wilmoth cited as validation for 
their results. They presented estimates for older ages for the age group 70+, but their 
method can be replicated with WHO Mortality Database (2010) data to produce 
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estimates for more specific age groups. This calculation indicates that the Peto-Lopez 
method estimates that approximately 41% of deaths due to smoking for women in the 
U.S. in 2000 were among women aged 80 and over. This proportion may actually be an 
overestimate. The Peto-Lopez method uses the same smoking-attributable fractions that 
were estimated for the 75-79 age group for those aged 80 and over because of concerns 
about the accuracy of mortality data at advanced ages. Rostron and Wilmoth 
(forthcoming) showed that this procedure can significantly increase the estimated 
number of smoking-attributable deaths for those aged 80 and over when smoking 
exposure is increasing appreciably for successive cohorts at older ages. Preston and 
Wang (2006) showed that smoking consistently increased among successive cohorts of 
U.S. women born in the first half of the 20th century.    
 
 
3. The proposed modified PGW-R method and results 
There is thus evidence that results from the PGW method for females differ from some 
other published estimates in terms of smoking-attributable mortality overall and by age. 
This article presents a modified version of the PGW method (the PGW-R method) that 
produces more plausible estimates. The PGW-R method introduces an age group-year 
interaction term into the method’s regression approach to better model mortality change 
from causes other than lung cancer by age group over time. All analyses with the PGW-
R method were conducted using an updated version of the dataset that was used by 
Preston, Glei, and Wilmoth for their article. This updated dataset was provided by the 
authors and is available as supplementary data on the International Journal of 
Epidemiology website. Analyses were conducted using R version 2.10.0.   
The PGW-R method introduces an age group-year interaction term [ ) a X ( at t× β ] 
into the regression equation shown in Equation 1. Year is treated as a linear variable, 
and the age groups 50-54 to 85+ are used in the interaction term. Inclusion of such an 
interaction term is reasonable in modeling mortality. The Lee-Carter method, 
commonly used to model and predict death rates, includes just two predictor terms – an 
age term and a term interacting age and period effects – in its model, in addition to an 
error term (Lee and Carter 1992). Inclusion of an age group-year term in the PGW 
regression model allows for change in mortality from causes other than lung cancer by 
age group to be better represented over time. Table 1 compares published estimates 
of
/
L β  for 2003 from the PGW method with estimates from the PGW-R method. Results 
for males from both methods are very similar, although use of the interaction term 
produces estimates of
/
L β   that consistently decrease with increasing age for all age 
groups. Results for females from the two methods are different for the oldest age 
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groups, although
/
L β  again consistently decreases with increasing age in results from the 
PGW-R method. Overall, estimates of smoking-attributable mortality for males with the 
two methods are quite similar. Preston, Glei, and Wilmoth estimated that 24% of deaths 
among U.S. males aged 50 and over in 2003 were attributable to smoking. The PGW-R 
method estimates that 22% of the deaths were due to smoking. Estimates are quite 
different for females, however. Preston, Glei, and Wilmoth estimated that 24% of 
deaths among U.S. females aged 50 and over in 2003 were attributable to smoking, 
which equals 271,000 deaths. The PGW-R method estimates that 14% of the deaths 
were due to smoking, which equals 166,000 deaths. This estimate is similar to the CDC 
estimate of 174,000 annual smoking-attributable deaths among U.S. females of all ages 
during the period.   
 
Table 1:  Coefficients for lung cancer death rates in 2003 from published and 
modified versions of the Preston, Glei, and Wilmoth (PGW) Method 
Preston, Glei, and Wilmoth (2010)   
PGW-R Method with Age Group-Year 
Interaction Term 
Age Group  Males Females    Males  Females 
50-54  0.342 0.699    0.348  0.707 
55-59  0.183 0.455    0.174  0.510 
60-64  0.113 0.281    0.113  0.382 
65-69  0.075 0.147    0.079  0.218 
70-74  0.053 0.072    0.060  0.137 
75-79  0.042 0.036    0.046  0.061 
80+  0.050 0.147    0.028  0.013 
 
Comparisons of estimates of smoking-attributable deaths for the U.S. by age group 
can also be made. These comparisons are done for 2000, due to the availability of 
published estimates for this year. Figure 1 shows the age breakdown of smoking-
attributable deaths as estimated by three methods: the PGW method, the PGW-R 
method, and the method used by Rogers et al., which is included for purposes of 
comparison. Estimates from the PGW method and Rogers et al. are similar for females 
younger than 80, but estimates from the PGW method are much larger than estimates 
from the other two methods for ages 80 and over. Estimates for males from the three 
methods are quite similar to age 65, and estimates from the PGW-R method are 
between those of the PGW method and Rogers et al. for ages 80 and over. 
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Figure 1:  Estimated smoking-attributable deaths by age group, U.S. 2000 
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Figure 1:  (Continued) 





















4. Evaluation of the proposed PGW-R method 
The proposed PGW-R method was evaluated through comparison of its results with 
those from a modified version of the Peto-Lopez method. The original Peto-Lopez 
method was modified in several ways. First, the lung cancer death rates and relative 
risks for other causes calculated from CPS-II data were replaced with deaths rates and 
relative risks calculated from more recent and representative NHIS data. Data for 1997-
2003 NHIS cohorts linked to mortality follow-up through the end of 2006 were used 
(NCHS 2010). CPS-II participants were recruited by American Cancer Society 
volunteers and tended to be more likely to be white, middle class, and college-educated 
than the U.S. population at the time of the study’s inception in 1982 (Thun 1997).  
Absolute mortality in the CPS-II during its follow-up period was lower than the 
mortality observed in the U.S. population at the time (Peto et al. 1992). The NHIS, on 
the other hand, is a nationally representative health survey of the U.S. household 
population (NCHS 2010). Table 2 and Figure 2 show results obtained from NHIS and 
CPS-II data. NHIS lung cancer death rates were substantially higher than CPS-II rates, 
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particularly for female smokers. This result could be caused by the low mortality 
observed in the CPS-II study population, as well as by a possible increase in smoking 
intensity and duration among U.S. female smokers over time. Unadjusted relative risks 
for other causes from the NHIS and CPS-II were generally similar, with the exception 
of upper aerodigestive cancers for males. Second, the NHIS relative risks for smokers 
for causes other than lung cancer were calculated while directly controlling for 
confounding risk factors, and all of the resulting excess relative risk was attributed to 
smoking. These relative risks were calculated using a Cox proportional hazards model. 
Controls for education (less than high school graduate, high school graduate, more than 
high school graduate), economic status (family income less than 100% of poverty 
threshold, 100%-149% of poverty threshold, 150%-199% of poverty threshold, 200% 
or more of poverty threshold), and weight (“underweight” or “normal” – Body Mass 
Index (BMI) < 25, “overweight” - 25 <= BMI < 30, “obese” – BMI > 30) were included 
for all causes. Controls for alcohol consumption (no alcohol consumption, “light to 
moderate alcohol consumption” -  1-2 drinks on average on days consuming alcohol for 
females and 1-3 drinks on average for males, and “heavy alcohol consumption” – 3+ 
drinks for females and 4+ drinks for males on average on days consuming alcohol) 
were included for upper aerodigestive cancers and other cancers. Relative risks for 
other medical causes for smokers aged 75-79 and 80 and over were calculated for 
current and former smokers compared to non-smokers, given that most smoking-
attributable deaths at these ages occur among former smokers (Rogers et al. 2005). The 
proportional hazards assumption of the Cox model was evaluated for each covariate 
using chi-squared tests of non-zero slope of the scaled Schoenfeld residuals as a 
function of time. The assumption was found to be valid for each covariate. Table 2 
shows that controlling for confounding factors generally lowered the NHIS relative 
risks, although the decreases were usually much less than the conservative halving of 
excess relative risk employed in the Peto-Lopez method. Finally, smoking-attributable 
fractions by cause were directly estimated for persons aged 80 and over, instead of the 
Peto-Lopez method’s use at these ages of the same SAF’s that were estimated for those 
75-79. 
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Table 2:  Relative mortality risks for current smokers compared to  
non-smokers: CPS-II and NHIS data 
CPS-II NHIS 
Causes of Death (ICD 9; 10) 
Males, RR  Females, RR  Males, RR  Males, CI  Females, RR  Females, CI 
Upper aerodigestive cancer (ICD 
140-150, 161; C00-C15, C32) 
7.87  6.95  2.56  1.48, 4.44 7.38  1.64, 33.27 
            
Other cancer (rest of ICD 140-209 
except 162; C16-C31, C35-C99) 
1.69  1.20  1.87  1.47, 2.38 1.30  1.07, 1.58 
            
Chronic obstructive pulmonary 
disease (ICD 490-2, 492-6; J40-
J47) 
13.82  14.21  14.19  5.61, 35.87 15.22  7.35, 31.54 
            
Cirrhosis, accidents, and violence 
(ICD 571, 800-999; K70, K73-K74, 
V01-Y99) 
— —  —  —  —  — 
            
Other medical causes (rest of ICD 
000-799 except 162; rest of A01-
R99 except C33-C34) 
          
ages 35-59  3.05  2.69  2.10  1.63, 2.70 2.92  2.25, 3.79 
  60-64  2.31  2.68  2.72  1.86, 3.96 2.25  1.55, 3.25 
  65-69  2.09  2.52  2.31  1.70, 3.14 2.69  1.96, 3.68 
  70-74  2.00  2.00  2.54  1.92, 3.35 1.86  1.36, 2.54 
  75+  1.54  1.44  1.60  1.33, 1.91 1.63  1.42, 1.87 
75-79            
80+            
 Demographic Research: Volume 23, Article 14 
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Table 2:  (Continued) 
NHIS - Adjusted for Confounding Factors
a
Causes of Death (ICD 9; 10) 
Males, RR  Males, CI  Females, RR  Females, CI 
Upper aerodigestive cancer (ICD 140-
150, 161; C00-C15, C32) 
1.98 1.08,  3.62  7.38
b 1.64, 33.27 
        
Other cancer (rest of ICD 140-209 
except 162; C16-C31, C35-C99) 
1.79  1.35, 2.38  1.32  1.05, 1.66 
        
Chronic obstructive pulmonary disease 
(ICD 490-2, 492-6; J40-J47) 
14.64  4.53, 47.36  9.60  4.64, 19.88 
        
Cirrhosis, accidents, and violence (ICD 
571, 800-999; K70, K73-K74, V01-Y99) 
— —  —  — 
        
Other medical causes (rest of ICD 000-
799 except 162; rest of A01-R99 except 
C33-C34) 
      
ages   35-59  2.10  1.54, 2.85  2.31  1.65, 3.23 
60-64  2.17  1.38, 3.40  1.91  1.24, 2.93 
65-69  2.09  1.40, 3.10  2.30  1.59, 3.33 
70-74  2.57  1.87, 3.52  1.83  1.26, 2.64 
75+  1.51  1.22, 1.86  1.64  1.39, 1.94 
75-79 1.48
c 1.13, 1.95  1.51  1.23, 1.85 
80+  1.10  0.96, 1.27  1.25  1.12, 1.39 
 
CPS-II = American Cancer Society Cancer Prevention Study II, NHIS = National Health Interview Survey, ICD = International 
Classification of Diseases, RR = Relative Risk, CI = Confidence Interval. 
‘—‘: No mortality from these causes was attributed to smoking.   
a Adjusted NHIS relative risks control for educational attainment, family income, body mass index, and alcohol consumption. 
b Adjusted NHIS relative risk for upper aerodigestive cancer was not calculated for females due to the small number of deaths for this 
group. 
c Adjusted NHIS relative risks for other medical causes for ages 75-79 and 80+ were calculated for current and former smokers 
compared to non-smokers. 
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Figure 2:  Lung cancer death rates by sex, age, and smoking status: 
Cancer Prevention Study II (CPS-II) and National Health Interview 
Survey (NHIS) data 
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Figure 2:  (Continued) 












































































Notes: Dashed lines indicate 95% confidence intervals for NHIS rates. CPS-II rates are from Peto et al. (1992). 
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Results from this modified version of the Peto-Lopez method are similar to some 
published estimates of smoking-attributable mortality for the U.S. The original Peto-
Lopez method estimates 269,000 smoking-attributable deaths for males and 243,000 
deaths for females in the U.S. in 2000 (Peto et al. 2006). The modified Peto-Lopez 
method estimates 254,000 deaths for males and 185,000 deaths for females in the U.S. 
in 2000, for a decrease of 6% for males and 24% for females compared to the original 
method. The CDC estimated 259,000 average annual smoking-attributable deaths for 
males and 178,000 deaths for females in the U.S. during the period from 1997 to 2001 
(2005), figures that are similar to those from the modified Peto-Lopez method. 
Results from the modified Peto-Lopez method are also very similar to results from 
the PGW-R method for the 20 high-income countries studied by Preston, Glei, and 
Wilmoth. Table 3 presents estimates of the smoking-attributable fraction of total deaths 
for males and females in these countries in 2000 from four methods: the Peto-Lopez 
method, the PGW method, the modified Peto-Lopez method, and the PGW-R method. 
Results from all four methods for males are fairly consistent, with the Peto-Lopez and 
PGW methods producing slightly higher SAF estimates than the modified Peto-Lopez 
method and PGW-R methods. Results are more divergent for females. SAF estimates 
from the Peto-Lopez and PGW methods are much higher for females than estimates 
from the modified Peto-Lopez and PGW-R methods, particularly for countries with 
high rates of smoking among women, such as Canada, Denmark, the U.K., and the U.S. 
Results from the PGW-R and modified Peto-Lopez methods are very consistent, 
with 99% correlation for females and 97% for males. The methodological 
improvements implemented in the modified Peto-Lopez method suggest that it is a 
better benchmark for comparison than the Peto-Lopez method. Comparison with results 
from the CDC and the modified Peto-Lopez methods indicates that the PGW-R method 
produces more accurate estimates of smoking-attributable mortality than the PGW 
method, particularly for females.  
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Results from this and other studies suggest that in this case the Peto-Lopez and 
PGW methods can produce similar overestimates of female smoking-attributable 
mortality, although for different reasons. Rostron and Wilmoth (forthcoming) argued 
that the Peto-Lopez method can overestimate female smoking-attributable mortality in 
high smoking countries such as the U.S., due to the method’s use of low CPS-II lung 
cancer death rates to estimate smoking exposure and its use of the same SAF’s 
estimated for persons aged 75-79 for persons aged 80 and over. Results from the 
modified Peto-Lopez method presented here generally support this idea. Similarly, 
elements of the original PGW method such as the lack of an age-period interaction term 
in its regression model appear to have produced an overestimate of   for females aged 
80 and over, and thus overestimation of smoking-attributable mortality for this group. Demographic Research: Volume 23, Article 14 
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Inclusion of an age-period interaction term in the model generally corrects for this 
problem and produces results that appear to be more accurate, particularly for females.  
 
Table 3:  Estimates of smoking-attributable fraction of deaths from selected 
methods, by country and sex: 2000 
Males 









Australia 0.20  0.20  0.17  0.17 
Austria 0.19  0.19  0.18  0.17 
Belgium
e 0.31 0.31 0.31  0.30 
Canada 0.25  0.25  0.22  0.22 
Denmark 0.25  0.25  0.22  0.21 
Finland 0.18  0.18  0.15  0.17 
France 0.21  0.21  0.19  0.19 
Hungary 0.31  0.32  0.31  0.31 
Iceland —  0.14  0.13  0.13 
Italy 0.25  0.25  0.24  0.23 
Japan 0.18  0.22  0.15  0.18 
The Netherlands  0.28  0.30  0.26  0.26 
New Zealand  0.20  0.18  0.18  0.16 
Norway 0.17  0.15  0.13  0.13 
Portugal 0.15  0.12  0.14  0.11 
Spain 0.25  0.22  0.23  0.20 
Sweden 0.10  0.10  0.07  0.09 
Switzerland 0.19  0.18  0.16  0.16 
UK 0.23  0.23  0.22  0.20 





 Rostron: A modified new method for estimating smoking-attributable mortality in high-income countries 
416   http://www.demographic-research.org 
Table 3:  (Continued) 
Females 









Australia 0.11  0.12  0.08  0.07 
Austria 0.06  0.07  0.04  0.04 
Belgium
e 0.05 0.05 0.03  0.04 
Canada 0.18  0.20  0.14  0.14 
Denmark 0.20  0.18  0.14  0.14 
Finland 0.04  0.04  0.02  0.03 
France 0.02  0.01  0.02  0.02 
Hungary 0.12  0.12  0.10  0.10 
Iceland —  0.21  0.14  0.15 
Italy 0.05  0.05  0.03  0.03 
Japan 0.06  0.12  0.05  0.05 
The Netherlands  0.10  0.07  0.07  0.07 
New Zealand  0.15  0.15  0.10  0.10 
Norway 0.10  0.06  0.06  0.06 
Portugal 0.01  0.01  0.01  0.01 
Spain 0.00  0.00  0.01  0.00 
Sweden 0.07  0.05  0.04  0.05 
Switzerland 0.06  0.05  0.03  0.04 
UK 0.16  0.16  0.11  0.11 
USA 0.20  0.22  0.16  0.14 
 
'—': Data are not available. 
a Estimates for the Peto-Lopez method are for ages 35+ and come from Peto et al. (2006). 
b Estimates for the PGW method are for ages 50+ and come from Preston, Glei, and Wilmoth (2010). 
c Estimates for the modified Peto-Lopez method are for ages 50+ and come from the modified method as described in this study. 
d Estimates for the PGW-R method are for ages 50+ and come from the revised method as described in this study. 
e Estimates for Belgium are based on 1997 data, due to inavailability of 2000 data in the WHO Mortality Database. 
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5. Summary and conclusion 
This article has examined the recently proposed PGW method to estimate smoking-
attributable mortality in high-income countries. This method is innovative and very 
useful in that it relies only on observed lung cancer and all-cause death rates to estimate 
smoking-attributable mortality. As a result, the method can be very useful in making 
comparisons among numerous countries and over a range of years. The method may 
also be more reliable for comparisons than methods that rely on smoking prevalence 
data from surveys that may be inconsistent across countries. The PGW method can be 
consistently used for most developed countries from at least 1950 onwards, and for 
some developing countries in more recent years using data from the WHO Mortality 
Database (2010). Results from the method as presented differ, however, from some 
published estimates, particularly with regard to the age distribution of smoking-
attributable deaths for females. This article has presented a modified version of the 
PGW method, the PGW-R method, which introduces an age-period interaction term 
into the regression analysis of the PGW method to better model mortality change over 
time by age for causes other than lung cancer. It has found that results from the PGW-R 
method are very similar to results from a modified version of the Peto-Lopez method 
for 20 high-income countries. The degree of consistency observed in the results tends to 
support the reliability of each method. Estimates of smoking-attributable mortality 
obtained with the PGW-R method for the U.S. are also similar to published estimates 
from the CDC, which further supports the reliability of this method. 
Additional research is needed to further evaluate and refine these methods and 
their results. In particular, additional information is needed about the age distribution of 
smoking-attributable deaths in various countries. The CDC, for example, does not 
publish such a breakdown in its periodic reports on smoking-attributable mortality in 
the U.S. (2008). Additional research is also needed to evaluate how well the PGW-R 
method performs for particular countries in addition to the U.S. Results from the PGW-
R method should be compared to results from the methods used to produce national 
estimates of smoking-attributable mortality in these countries. 
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